POINT Biopharma Global (PNT) Q3 2023 Earnings

Nov 13Confirmed
Nov 2022
Q1 2023
Q2 2023
Q3 2023
-0.31
-0.26
-0.21
-0.16

Details

Expected EPS
-0.3
Actual EPS
-0.23
Surprise EPS
0.07
Surprise Percent
+23.33%

Description

⁨POINT Biopharma Global⁩ (⁦PNT⁩) has reported earnings of ⁦-0.23⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts